Fabien Vial

Fabien Vial joined Enzyvant in September 2020, bringing over 20 years of global financial leadership experience in the pharmaceutical sector.

Before joining Enzyvant, Fabien held numerous leadership positions at Alexion, including as the Head of Financial Planning and Analysis (FP&A) for the EMEA region, Head of Finance for the MidSize Markets and finally as the Finance Lead for strategic corporate FP&A projects.

Previously, Fabien served in roles of increasing responsibility with Shire Pharmaceuticals, from country CFO of the French affiliate, Head of Finance for the U.K. and Ireland affiliates and Head of Finance Business Partnering for all Specialty Pharmaceutical business outside of the U.S.

Fabien holds a degree in Finance from Institut Commercial de Nancy (I.C.N.) Business School in France.